These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 2833355

  • 21. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Restriction fine specificity of long-term, hapten-specific cytotoxic T cell clones: analysis with H-2Kbm-mutant mice and H-2Kb-specific monoclonal antibodies.
    Pircher H, Hämmerling G, Hengartner H.
    Eur J Immunol; 1984 Feb; 14(2):144-52. PubMed ID: 6199212
    [Abstract] [Full Text] [Related]

  • 25. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR.
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [Abstract] [Full Text] [Related]

  • 26. Cross-reactive recognition of mouse cells expressing the bm3 and bm11 mutations within H-2Kb by H-2Kb-restricted herpes simplex virus-specific cytotoxic T lymphocytes.
    Jennings SR.
    J Immunol; 1985 Nov; 135(5):3530-6. PubMed ID: 2413124
    [Abstract] [Full Text] [Related]

  • 27. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F, Lilly F.
    J Exp Med; 1979 Nov 01; 150(5):1174-86. PubMed ID: 91655
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M, Oehen S, Schulz M, Hengartner H, Mackett M, Bishop DH, Overton H, Zinkernagel RM.
    Eur J Immunol; 1989 Mar 01; 19(3):417-24. PubMed ID: 2468501
    [Abstract] [Full Text] [Related]

  • 31. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Nov 01; 133(5):2736-42. PubMed ID: 6207243
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F, Collavo D, Zanovello P, Cerundolo V, Biasi G.
    Immunology; 1985 Feb 01; 54(2):265-74. PubMed ID: 2578429
    [Abstract] [Full Text] [Related]

  • 35. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ, Boes J, Melief CJ.
    J Immunol; 1984 Jul 01; 133(1):24-7. PubMed ID: 6202782
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones.
    Lukacher AE, Morrison LA, Braciale VL, Malissen B, Braciale TJ.
    J Exp Med; 1985 Jul 01; 162(1):171-87. PubMed ID: 2409206
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen.
    Mylin LM, Deckhut AM, Bonneau RH, Kierstead TD, Tevethia MJ, Simmons DT, Tevethi SS.
    Virology; 1995 Apr 01; 208(1):159-72. PubMed ID: 11831696
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.